Robert W. Baird Has Lowered Expectations for Intuitive Surgical (NASDAQ:ISRG) Stock Price

Intuitive Surgical (NASDAQ:ISRG) had its price target dropped by equities research analysts at Robert W. Baird from $707.00 to $600.00 in a report released on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the medical equipment provider’s stock. Robert W. Baird’s price target indicates a potential upside of 21.94% from the stock’s previous close.

Other equities research analysts have also recently issued reports about the company. Jefferies Financial Group raised their price target on Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Leerink Partners raised their price target on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Evercore ISI raised their price target on Intuitive Surgical from $490.00 to $530.00 in a report on Monday, January 27th. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Tuesday, November 19th. Finally, Wells Fargo & Company lifted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and an average target price of $611.86.

Intuitive Surgical Stock Up 1.7 %

NASDAQ:ISRG opened at $492.06 on Tuesday. The business’s 50-day simple moving average is $564.39 and its two-hundred day simple moving average is $531.62. The stock has a market cap of $175.26 billion, a PE ratio of 76.76, a P/E/G ratio of 5.85 and a beta of 1.43. Intuitive Surgical has a 52 week low of $364.17 and a 52 week high of $616.00.

Insider Buying and Selling at Intuitive Surgical

In other news, Director Amal M. Johnson sold 4,635 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total transaction of $2,626,191.00. Following the completion of the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. The trade was a 27.41 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Brian Edward Miller sold 8,900 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 11th. The shares were sold at an average price of $485.07, for a total transaction of $4,317,123.00. Following the sale, the executive vice president now directly owns 5,758 shares of the company’s stock, valued at $2,793,033.06. This represents a 60.72 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock worth $17,691,621 over the last 90 days. Company insiders own 0.90% of the company’s stock.

Institutional Trading of Intuitive Surgical

Several institutional investors and hedge funds have recently modified their holdings of ISRG. Norges Bank bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $2,401,493,000. Massachusetts Financial Services Co. MA bought a new position in Intuitive Surgical in the third quarter worth approximately $558,807,000. Proficio Capital Partners LLC raised its stake in Intuitive Surgical by 89,098.8% in the fourth quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock worth $495,845,000 after buying an additional 948,902 shares in the last quarter. FMR LLC raised its stake in Intuitive Surgical by 8.3% in the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after buying an additional 838,793 shares in the last quarter. Finally, Capital Research Global Investors raised its stake in Intuitive Surgical by 25.5% in the fourth quarter. Capital Research Global Investors now owns 3,381,302 shares of the medical equipment provider’s stock worth $1,764,904,000 after buying an additional 687,906 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.